(EXP) Eagle Materials - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26969P1084
Stock: Cement, Concrete, Aggregates, Wallboard, Paperboard
Total Rating 38
Risk 85
Buy Signal -1.34
| Risk 5d forecast | |
|---|---|
| Volatility | 32.5% |
| Relative Tail Risk | -2.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.21 |
| Alpha | -37.20 |
| Character TTM | |
|---|---|
| Beta | 1.424 |
| Beta Downside | 0.876 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.54% |
| CAGR/Max DD | 0.32 |
EPS (Earnings per Share)
Revenue
Description: EXP Eagle Materials March 05, 2026
Eagle Materials Inc. (EXP) manufactures and sells construction products and building materials. The company operates in four segments: Cement, Concrete and Aggregates, Gypsum Wallboard, and Recycled Paperboard.
EXPs business model involves the extraction and processing of raw materials like limestone and gypsum to produce cement, concrete, wallboard, and paperboard. These materials are fundamental to the construction sector, serving residential, commercial, and public infrastructure projects. The construction materials industry is cyclical, influenced by economic growth and interest rates.
The companys offerings also include recycled paperboard, which is used in the gypsum wallboard industry and by other converters. This highlights a vertically integrated aspect of their operations, where one product (recycled paperboard) supports another core product (gypsum wallboard).
For more detailed financial analysis and performance metrics, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Residential construction demand drives gypsum wallboard sales
- Infrastructure spending boosts cement and concrete demand
- Raw material cost fluctuations impact profit margins
- Interest rate hikes cool construction activity
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 430.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -6.12 > 1.0 |
| NWC/Revenue: 34.38% < 20% (prev 17.41%; Δ 16.97% < -1%) |
| CFO/TA 0.15 > 3% & CFO 574.8m > Net Income 430.1m |
| Net Debt (1.38b) to EBITDA (779.2m): 1.77 < 3 |
| Current Ratio: 4.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.4m) vs 12m ago -3.51% < -2% |
| Gross Margin: 28.30% > 18% (prev 0.30%; Δ 2.80k% > 0.5%) |
| Asset Turnover: 66.78% > 50% (prev 74.48%; Δ -7.70% > 0%) |
| Interest Coverage Ratio: 8.85 > 6 (EBITDA TTM 779.2m / Interest Expense TTM 69.3m) |
Altman Z'' 4.48
| A: 0.21 (Total Current Assets 1.03b - Total Current Liabilities 241.5m) / Total Assets 3.84b |
| B: 0.39 (Retained Earnings 1.50b / Total Assets 3.84b) |
| C: 0.18 (EBIT TTM 613.9m / Avg Total Assets 3.44b) |
| D: 0.64 (Book Value of Equity 1.49b / Total Liabilities 2.35b) |
| Altman-Z'' Score: 4.48 = AA |
Beneish M -2.88
| DSRI: 1.16 (Receivables 216.6m/184.1m, Revenue 2.30b/2.27b) |
| GMI: 1.07 (GM 28.30% / 30.36%) |
| AQI: 0.96 (AQ_t 0.21 / AQ_t-1 0.22) |
| SGI: 1.01 (Revenue 2.30b / 2.27b) |
| TATA: -0.04 (NI 430.1m - CFO 574.8m) / TA 3.84b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of EXP shares?
As of March 16, 2026, the stock is trading at USD 186.47 with a total of 352,875 shares traded.
Over the past week, the price has changed by -5.24%, over one month by -20.69%, over three months by -16.36% and over the past year by -9.71%.
Over the past week, the price has changed by -5.24%, over one month by -20.69%, over three months by -16.36% and over the past year by -9.71%.
Is EXP a buy, sell or hold?
Eagle Materials has received a consensus analysts rating of 3.64.
Therefor, it is recommend to hold EXP.
- StrongBuy: 3
- Buy: 1
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EXP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 222.6 | 19.3% |
| Analysts Target Price | 222.6 | 19.3% |
EXP Fundamental Data Overview March 15, 2026
P/E Trailing = 14.8858
P/E Forward = 15.3139
P/S = 2.7437
P/B = 4.1413
P/EG = 2.0851
Revenue TTM = 2.30b USD
EBIT TTM = 613.9m USD
EBITDA TTM = 779.2m USD
Long Term Debt = 1.75b USD (from longTermDebt, last quarter)
Short Term Debt = 19.2m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.38b USD (from netDebt column, last quarter)
Enterprise Value = 7.69b USD (6.31b + Debt 1.80b - CCE 419.0m)
Interest Coverage Ratio = 8.85 (Ebit TTM 613.9m / Interest Expense TTM 69.3m)
EV/FCF = 33.18x (Enterprise Value 7.69b / FCF TTM 231.8m)
FCF Yield = 3.01% (FCF TTM 231.8m / Enterprise Value 7.69b)
FCF Margin = 10.08% (FCF TTM 231.8m / Revenue TTM 2.30b)
Net Margin = 18.70% (Net Income TTM 430.1m / Revenue TTM 2.30b)
Gross Margin = 28.30% ((Revenue TTM 2.30b - Cost of Revenue TTM 1.65b) / Revenue TTM)
Gross Margin QoQ = 28.94% (prev 31.26%)
Tobins Q-Ratio = 2.00 (Enterprise Value 7.69b / Total Assets 3.84b)
Interest Expense / Debt = 0.76% (Interest Expense 13.7m / Debt 1.80b)
Taxrate = 20.38% (26.3m / 129.2m)
NOPAT = 488.8m (EBIT 613.9m * (1 - 20.38%))
Current Ratio = 4.27 (Total Current Assets 1.03b / Total Current Liabilities 241.5m)
Debt / Equity = 1.21 (Debt 1.80b / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = 1.77 (Net Debt 1.38b / EBITDA 779.2m)
Debt / FCF = 5.96 (Net Debt 1.38b / FCF TTM 231.8m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.49% (Net Income 430.1m / Total Assets 3.84b)
RoE = 28.78% (Net Income TTM 430.1m / Total Stockholder Equity 1.49b)
RoCE = 18.93% (EBIT 613.9m / Capital Employed (Equity 1.49b + L.T.Debt 1.75b))
RoIC = 16.89% (NOPAT 488.8m / Invested Capital 2.89b)
WACC = 8.86% (E(6.31b)/V(8.11b) * Re(11.22%) + D(1.80b)/V(8.11b) * Rd(0.76%) * (1-Tc(0.20)))
Discount Rate = 11.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.40%
[DCF] Terminal Value 73.37% ; FCFF base≈287.0m ; Y1≈261.2m ; Y5≈229.1m
[DCF] Fair Price = 68.15 (EV 3.52b - Net Debt 1.38b = Equity 2.14b / Shares 31.4m; r=8.86% [WACC]; 5y FCF grow -11.19% → 2.90% )
EPS Correlation: 28.72 | EPS CAGR: 15.10% | SUE: -0.45 | # QB: 0
Revenue Correlation: 37.69 | Revenue CAGR: 8.24% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.29 | Chg7d=-0.234 | Chg30d=-0.378 | Revisions Net=-4 | Analysts=9
EPS next Year (2027-03-31): EPS=12.57 | Chg7d=+0.025 | Chg30d=-1.265 | Revisions Net=-11 | Growth EPS=-1.8% | Growth Revenue=+1.6%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 11.2% - Earnings Yield 6.7%)
[Growth] Growth Spread = -7.4% (Analyst -2.9% - Implied 4.5%)
P/E Forward = 15.3139
P/S = 2.7437
P/B = 4.1413
P/EG = 2.0851
Revenue TTM = 2.30b USD
EBIT TTM = 613.9m USD
EBITDA TTM = 779.2m USD
Long Term Debt = 1.75b USD (from longTermDebt, last quarter)
Short Term Debt = 19.2m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.38b USD (from netDebt column, last quarter)
Enterprise Value = 7.69b USD (6.31b + Debt 1.80b - CCE 419.0m)
Interest Coverage Ratio = 8.85 (Ebit TTM 613.9m / Interest Expense TTM 69.3m)
EV/FCF = 33.18x (Enterprise Value 7.69b / FCF TTM 231.8m)
FCF Yield = 3.01% (FCF TTM 231.8m / Enterprise Value 7.69b)
FCF Margin = 10.08% (FCF TTM 231.8m / Revenue TTM 2.30b)
Net Margin = 18.70% (Net Income TTM 430.1m / Revenue TTM 2.30b)
Gross Margin = 28.30% ((Revenue TTM 2.30b - Cost of Revenue TTM 1.65b) / Revenue TTM)
Gross Margin QoQ = 28.94% (prev 31.26%)
Tobins Q-Ratio = 2.00 (Enterprise Value 7.69b / Total Assets 3.84b)
Interest Expense / Debt = 0.76% (Interest Expense 13.7m / Debt 1.80b)
Taxrate = 20.38% (26.3m / 129.2m)
NOPAT = 488.8m (EBIT 613.9m * (1 - 20.38%))
Current Ratio = 4.27 (Total Current Assets 1.03b / Total Current Liabilities 241.5m)
Debt / Equity = 1.21 (Debt 1.80b / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = 1.77 (Net Debt 1.38b / EBITDA 779.2m)
Debt / FCF = 5.96 (Net Debt 1.38b / FCF TTM 231.8m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.49% (Net Income 430.1m / Total Assets 3.84b)
RoE = 28.78% (Net Income TTM 430.1m / Total Stockholder Equity 1.49b)
RoCE = 18.93% (EBIT 613.9m / Capital Employed (Equity 1.49b + L.T.Debt 1.75b))
RoIC = 16.89% (NOPAT 488.8m / Invested Capital 2.89b)
WACC = 8.86% (E(6.31b)/V(8.11b) * Re(11.22%) + D(1.80b)/V(8.11b) * Rd(0.76%) * (1-Tc(0.20)))
Discount Rate = 11.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.40%
[DCF] Terminal Value 73.37% ; FCFF base≈287.0m ; Y1≈261.2m ; Y5≈229.1m
[DCF] Fair Price = 68.15 (EV 3.52b - Net Debt 1.38b = Equity 2.14b / Shares 31.4m; r=8.86% [WACC]; 5y FCF grow -11.19% → 2.90% )
EPS Correlation: 28.72 | EPS CAGR: 15.10% | SUE: -0.45 | # QB: 0
Revenue Correlation: 37.69 | Revenue CAGR: 8.24% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.29 | Chg7d=-0.234 | Chg30d=-0.378 | Revisions Net=-4 | Analysts=9
EPS next Year (2027-03-31): EPS=12.57 | Chg7d=+0.025 | Chg30d=-1.265 | Revisions Net=-11 | Growth EPS=-1.8% | Growth Revenue=+1.6%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 11.2% - Earnings Yield 6.7%)
[Growth] Growth Spread = -7.4% (Analyst -2.9% - Implied 4.5%)